An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
Essent continues to broaden its highly characterized, low passage primary cell catalog
This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan
Novel delivery of established growth and neurotrophic factors enables local, sustained release for greater efficacy
A single-cell analysis solution that revolutionizes efficiency in drug discovery research by automating the collection of specific cells and intracellular components
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
The collaboration of two strong partners, CELLINK and UPM, builds confidence in making these treatments into an industrial and clinical standard, applied in a wider setting instead of remaining only within few hospitals.
Subscribe To Our Newsletter & Stay Updated
